MoneyWorks4Me

Morepen Laboratories - Quaterly Results

21 May 2024 Evaluate
The company witnessed a 16.66% growth in the revenue at Rs. 3926.00 millions for the quarter ended March 2024 as compared to Rs. 3365.24 millions during the year-ago period.Net Profit for the quarter ended March 2024 zoomed to 288.90% from Rs. 102.75 millions to Rs. 399.59  millions.The company reported a good operating profit of 601.22 millions compared to 181.17 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 3926.00 3365.24 16.66 15375.94 13388.83 14.84 15375.94 13388.83 14.84
Other Income 39.86 29.88 33.40 125.66 57.59 118.20 125.66 57.59 118.20
PBIDT 601.22 181.17 231.85 1743.84 830.29 110.03 1743.84 830.29 110.03
Interest 7.28 5.62 29.54 35.09 19.81 77.13 35.09 19.81 77.13
PBDT 593.94 175.55 238.33 1708.75 810.48 110.83 1708.75 810.48 110.83
Depreciation 66.88 46.14 44.95 219.00 180.06 21.63 219.00 180.06 21.63
PBT 527.06 129.41 307.28 1489.75 630.42 136.31 1489.75 630.42 136.31
TAX 127.47 26.66 378.13 380.40 167.99 126.44 380.40 167.99 126.44
Deferred Tax -4.36 2.03 -314.78 -4.36 2.03 -314.78 -4.36 2.03 -314.78
PAT 399.59 102.75 288.90 1109.35 462.43 139.90 1109.35 462.43 139.90
Equity 1022.27 1022.27 0.00 1022.27 1022.27 0.00 1022.27 1022.27 0.00
PBIDTM(%) 15.31 5.38 184.45 11.34 6.20 82.88 11.34 6.20 82.88
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..